| SINOPHARM GROUP ADR |
| USA |
| Handel |
| US82937K1016 / A2P3LX |
| X2S1 (Frankfurt) |
| FRA:X2S1, ETR:X2S1, X2S1:GR |
| - |
| http://ir.sinopharmgroup... |
|
Sinopharm Group Co. Ltd. is a prominent player in the pharmaceutical and healthcare industry in China. As a state-owned enterprise, Sinopharm focuses on various aspects of the healthcare system, including the research, development, manufacturing, dis..
>Volltext.. |
| 7023 Mio. EUR |
| 19052.66 Mio. EUR |
| 69180.74 Mio. EUR |
| 2522.13 Mio. EUR |
| 860.81 Mio. EUR |
| 1.38 EUR |
| 13434.49 Mio. EUR |
| 7616.74 Mio. EUR |
| 1715.89 Mio. EUR |
| 0.25 |
| -1.48% |
| 1.65% |
| 0.4 EUR |
| 2.73% |
| 2.72% |
| 17.06.25 - 0.40304464€ 18.06.24 - 0.52547604€ >weitere anzeigen... |
| - |
| SINOPHARM ADR, SINOPHARM |
| 01.04.26 |
|